Milgram L - Search Results

1

Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study.

Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, Wilmott RW, Zeitlin P, Ramsey B; Cystic Fibrosis Therapeutics Development Research Group. Noone PG, et al. Among authors: milgram l. Pediatr Pulmonol. 2001 Aug;32(2):122-8. doi: 10.1002/ppul.1098. Pediatr Pulmonol. 2001. PMID: 11477729 Clinical Trial.

2

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.

Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, Mathews D, Gorden J, Schaberg A, Williams J, Ramsey B; Cystic Fibrosis Foundation Therapeutics Development Network. Deterding R, et al. Among authors: milgram l. Pediatr Pulmonol. 2005 Apr;39(4):339-48. doi: 10.1002/ppul.20192. Pediatr Pulmonol. 2005. PMID: 15704203 Clinical Trial.

3

A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis.

McCarty NA, Standaert TA, Teresi M, Tuthill C, Launspach J, Kelley TJ, Milgram LJ, Hilliard KA, Regelmann WE, Weatherly MR, Aitken ML, Konstan MW, Ahrens RC. McCarty NA, et al. Among authors: milgram lj. Pediatr Pulmonol. 2002 Feb;33(2):90-8. doi: 10.1002/ppul.10041. Pediatr Pulmonol. 2002. PMID: 11802244 Clinical Trial.

4

Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis.

Ahrens RC, Standaert TA, Launspach J, Han SH, Teresi ME, Aitken ML, Kelley TJ, Hilliard KA, Milgram LJ, Konstan MW, Weatherly MR, McCarty NA. Ahrens RC, et al. Among authors: milgram lj. Pediatr Pulmonol. 2002 Feb;33(2):142-50. doi: 10.1002/ppul.10043. Pediatr Pulmonol. 2002. PMID: 11802252

5

Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials.

Standaert TA, Boitano L, Emerson J, Milgram LJ, Konstan MW, Hunter J, Berclaz PY, Brass L, Zeitlin PL, Hammond K, Davies Z, Foy C, Noone PG, Knowles MR. Standaert TA, et al. Among authors: milgram lj. Pediatr Pulmonol. 2004 May;37(5):385-92. doi: 10.1002/ppul.10448. Pediatr Pulmonol. 2004. PMID: 15095320

6

A multicenter study of the effect of solution temperature on nasal potential difference measurements.

Boyle MP, Diener-West M, Milgram L, Knowles M, Foy C, Zeitlin P, Standaert T; Cystic Fibrosis Therapeutics Development Network Nasal PD Study Group. Boyle MP, et al. Among authors: milgram l. Chest. 2003 Aug;124(2):482-9. doi: 10.1378/chest.124.2.482. Chest. 2003. PMID: 12907532 Clinical Trial.

7

Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.

Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, Cooper MJ. Konstan MW, et al. Among authors: milgram lj. Hum Gene Ther. 2004 Dec;15(12):1255-69. doi: 10.1089/hum.2004.15.1255. Hum Gene Ther. 2004. PMID: 15684701 Clinical Trial.

8

Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.

Geller D, Thipphawong J, Otulana B, Caplan D, Ericson D, Milgram L, Okikawa J, Quan J, Bowman CM. Geller D, et al. Among authors: milgram l. J Aerosol Med. 2003 Summer;16(2):175-82. doi: 10.1089/089426803321919933. J Aerosol Med. 2003. PMID: 12823911

9

In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium.

Kelley TJ, Thomas K, Milgram LJ, Drumm ML. Kelley TJ, et al. Among authors: milgram lj. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2604-8. doi: 10.1073/pnas.94.6.2604. Proc Natl Acad Sci U S A. 1997. PMID: 9122242 Free PMC article.

10

Asthma medications should be available for over-the-counter use: con.

Milgram LJ. Milgram LJ. Ann Am Thorac Soc. 2014 Jul;11(6):975-9. doi: 10.1513/AnnalsATS.201403-129AR. Ann Am Thorac Soc. 2014. PMID: 24964175 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters